Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old

PHASE3CompletedINTERVENTIONAL
Enrollment

2,333

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Influenza
Interventions
BIOLOGICAL

QIVc

Novartis Investigational Quadrivalent Vaccine

BIOLOGICAL

TIV1c

Licensed Influenza Vaccine

BIOLOGICAL

TIV2c

Novartis Investigational Vaccine

Trial Locations (88)

13901

Binghamton

15241

Upper Saint Clair

16148

Hermitage

16505

Erie

16508

Erie

18960

Sellersville

22015

Burke

22902

Charlottesville

28401

Wilmington

29403

Charleston

29464

Mt. Pleasant

29621

Anderson

30062

Marietta

30189

Woodstock

30338

Atlanta

32746

Lake Mary

32935

Melbourne

33055

Opa-locka

33141

Miami Beach

33432

Boca Raton

33781

Pinellas Park

35802

Huntsville

36608

Mobile

37087

Lebanon

37203

Nashville

37620

Bristol

37760

Jefferson City

40291

Louisville

40509

Lexington

44106

Cleveland

44122

Cleveland

44311

Akron

45249

Cincinnati

45406

Dayton

45414

Dayton

45429

Kettering

46545

Mishawaka

51503

Council Bluffs

61602

Peoria

63141

St Louis

64114

Kansas City

67010

Wichita

67114

Newton

67207

Wichita

68005

Bellevue

68025

Fremont

68114

Omaha

68134

Omaha

70006

Metairie

72401

Jonesboro

72452

Harrisburg

73103

Oklahoma City

73112

Oklahoma City

74127

Tulsa

75231

Dallas

76107

Fort Worth

76135

Fort Worth

76904

San Angelo

78229

San Antonio

78681

Round Rock

78705

Austin

80233

Thornton

80246

Denver

80249

Denver

80907

Colorado Springs

83642

Boise

84020

Draper

84041

Layton

84088

West Jordan

84095

South Jordan

84109

Salt Lake City

84121

Salt Lake City

84124

Salt Lake City

85206

Mesa

85213

Mesa

85224

Chandler

89104

Las Vegas

90241

Downey

90723

Paramount

91790

West Covina

92801

Anaheim

92804

Anaheim

92844

Garden Grove

94102

San Francisco

95350

Modesto

95405

Santa Rosa

95816

Sacramento

92103-6204

San Diego

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novartis Vaccines

INDUSTRY

NCT01992107 - Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old | Biotech Hunter | Biotech Hunter